Clinical Trial Update: Medical Treatment for Gastroesophageal Reflux Disease (GERD) in Preterm Infants [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating medical treatment for gastroesophageal reflux disease in preterm infants has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Gastroesophageal Reflux | Phase 3 | Status: COMPLETED | Results posted: 2014-01-15